Author

D. L. Ludwig

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

E. Dadachova· 1 shared E. M. Geoghegan· 1 shared K. J. Allen· 1 shared R. Garg· 1 shared W. Dawicki· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

E. Dadachova

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

225Ac-labeled CD33-targeting antibody reverses resistance to Bcl-2 inhibitor venetoclax in acute myeloid leukemia models

R. Garg, K. J. Allen, W. Dawicki, E. M. Geoghegan, D. L. Ludwig, E. Dadachova

This study shows that combining 225Ac-lintuzumab with venetoclax enhances tumor cell killing and improves survival in venetoclax-resistant AML models by inducing DNA damage and reducing MCL-1 levels.

bioRxiv · Oct 9, 2020Cancer Biology